Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Kast

Showing results (31-40 of 175) with videos related to

Pageof 18
Sort By:
Oncology|January 1, 1975
Lymphocytes and cells in malignant transformation: similarities and possible relationship between the two cell typesR E Kast
Experimental Lung Research|April 15, 2020
Dapsone as treatment adjunct in ARDSR E Kast
Neoplasia (New York, N.Y.)|March 28, 2003
Ribavirin in cancer immunotherapies: controlling nitric oxide augments cytotoxic lymphocyte functionRichard E Kast
Bone Marrow Transplantation|October 2, 2007
How lithium treatment generates neutrophilia by enhancing phosphorylation of GSK-3, increasing HIF-1 levels and how this path is important during engraftmentR E Kast
Journal of Neuro-Oncology|April 28, 2007
Using blood brain barrier disruption by methamphetamine for drug deliveryR E Kast
Inflammopharmacology|December 2, 2006
Aspirin, TNF-alpha, NFkB, and survival in multiple myeloma: the importance of measuring TNF-alphaR E Kast
Medical Oncology (Northwood, London, England)|August 4, 2007
Melanoma inhibition by cyclooxygenase inhibitors: role of interleukin-6 suppression, a putative mechanism of action, and clinical implicationsR E Kast
Medical Hypotheses|November 23, 2006
Some fibrocystic breast change may be caused by sexually transmitted H. pylori during oral nipple contact: supporting literature and case report of resolution after gut H. pylori eradication treatmentR E Kast
Journal of Neuro-Oncology|March 27, 2009
Use of FDA approved methamphetamine to allow adjunctive use of methylnaltrexone to mediate core anti-growth factor signaling effects in glioblastomaR E Kast
Gastroenterology|October 24, 1998
Crohn's disease remission with phenelzine treatmentR E Kast
Pageof 18

Showing results (31-40 of 175) with videos related to

Sort By:
Pageof 18
Oncology|January 1, 1975
Lymphocytes and cells in malignant transformation: similarities and possible relationship between the two cell typesR E Kast
Experimental Lung Research|April 15, 2020
Dapsone as treatment adjunct in ARDSR E Kast
Neoplasia (New York, N.Y.)|March 28, 2003
Ribavirin in cancer immunotherapies: controlling nitric oxide augments cytotoxic lymphocyte functionRichard E Kast
Bone Marrow Transplantation|October 2, 2007
How lithium treatment generates neutrophilia by enhancing phosphorylation of GSK-3, increasing HIF-1 levels and how this path is important during engraftmentR E Kast
Journal of Neuro-Oncology|April 28, 2007
Using blood brain barrier disruption by methamphetamine for drug deliveryR E Kast
Inflammopharmacology|December 2, 2006
Aspirin, TNF-alpha, NFkB, and survival in multiple myeloma: the importance of measuring TNF-alphaR E Kast
Medical Oncology (Northwood, London, England)|August 4, 2007
Melanoma inhibition by cyclooxygenase inhibitors: role of interleukin-6 suppression, a putative mechanism of action, and clinical implicationsR E Kast
Medical Hypotheses|November 23, 2006
Some fibrocystic breast change may be caused by sexually transmitted H. pylori during oral nipple contact: supporting literature and case report of resolution after gut H. pylori eradication treatmentR E Kast
Journal of Neuro-Oncology|March 27, 2009
Use of FDA approved methamphetamine to allow adjunctive use of methylnaltrexone to mediate core anti-growth factor signaling effects in glioblastomaR E Kast
Gastroenterology|October 24, 1998
Crohn's disease remission with phenelzine treatmentR E Kast
Pageof 18